Lapatem 250mg Tablet
By Lapatem
Rx
30 Tablet in a Bottle

Composition
Lapatinib(250mg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
May, 2026

liver
Caution should be taken when using Lapatem 250mg Tablet in individuals with liver disease. It may be necessary to adjust the dosage of the tablet in such cases. It is advised to consult with your doctor before using Lapatem 250mg Tablet, especially for patients with severe liver disease as there is limited information available on its use in this particular condition.

kidney
Caution should be taken when using Lapatem 250mg Tablet in patients with severe kidney disease as dose adjustment may be necessary. Consult your doctor as limited information is available for this group. No dose adjustment is needed for patients with mild to moderate kidney disease.

alcohol
Consult your doctor when consuming alcohol with Lapatem 250mg Tablet.

driving
When taking Lapatem 250mg Tablet, be cautious while driving, as it may cause side effects that can impact your driving ability.

pregnancy
Lapatem 250mg Tablet is not safe for use during pregnancy due to potential risk to the developing baby. Consult your doctor before use, as they may only prescribe it in life-threatening situations if benefits outweigh risks.

breastfeeding
Caution should be taken during breastfeeding, as Lapatem 250mg Tablet is considered unsafe due to potential toxicity to the baby. It is better to consult your doctor before using Lapatem 250mg Tablet.
Habit Forming | No |
Chemical Class | Quinazolinamines Derivative |
Therapeutic Class | ANTI NEOPLASTICS |
Action Class | Tyrosine kinase inhibitors |
₹6745
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024